Why is Assembly Biosciences stock surging today?
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Assembly Biosciences Inc (ASMB)
Assembly Biosciences Inc stock price live, this page displays NASDAQ ASMB stock exchange data. View the ASMB premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Assembly Biosciences Inc real time stock price chart below.
What Is the Assembly Biosciences Inc Stock Price Today?
The Assembly Biosciences Inc stock price today is 29.800.
What Is the Stock Symbol for Assembly Biosciences Inc?
The stock symbol for Assembly Biosciences Inc is "ASMB."
What Stock Exchange Does Assembly Biosciences Inc Trade On?
Assembly Biosciences Inc is listed and trades on the NASDAQ stock exchange.
Is Assembly Biosciences Inc a Good Stock to Buy?
Determining whether Assembly Biosciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ASMB quote. (ISIN: US0453962070)
What Is the Assembly Biosciences Inc Stock Price Today?
The Assembly Biosciences Inc stock price today is 29.800.
What Is the Stock Symbol for Assembly Biosciences Inc?
The stock symbol for Assembly Biosciences Inc is "ASMB."
What Stock Exchange Does Assembly Biosciences Inc Trade On?
Assembly Biosciences Inc is listed and trades on the NASDAQ stock exchange.
Is Assembly Biosciences Inc a Good Stock to Buy?
Determining whether Assembly Biosciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ASMB quote. (ISIN: US0453962070)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
29.680
31.720
52 wk Range
20.230
39.705
ASMB is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
29.68031.720
52 wk Range
20.23039.705
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ASMB Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
52.000
Upside
+74.50%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
- Why is Assembly Biosciences stock surging today?
- Investing.com
Ventrus Bioscienc receives Investment Bank Analyst Rating Update- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 52.000
(+74.50% Upside)
Earnings
Latest Release
Aug 13, 2026
EPS / Forecast
-0.20 / -0.73
Revenue / Forecast
13.37M / 8.6M
Compare ASMB to Peers and Sector
Metrics to compare | ASMB | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipASMBPeersSector | |
|---|---|---|---|---|
P/E Ratio | −14,446.3x | −1.7x | −0.4x | |
PEG Ratio | - | −0.05 | 0.00 | |
Price/Book | 2.0x | 2.7x | 2.6x | |
Price / LTM Sales | 8.1x | 4.6x | 3.0x | |
Upside (Analyst Target) | 74.5% | 150.4% | 55.1% | |
Fair Value Upside | Unlock | 17.0% | 8.2% | Unlock |
Assembly Biosciences, Inc., a biotechnology company, develops therapeutic candidates for the treatment of viral diseases worldwide. Its pipeline includes long-acting helicase-primase inhibitors candidates, including ABI-5366 and ABI-1179, which are in Phase 1 clinical studies for recurrent genital herpes; and ABI-6250, an orally bioavailable hepatitis delta virus entry inhibitor that is in Phase 1a clinical study for the treatment of chronic hepatitis delta virus (HDV) infection. The company also develops ABI-4334, an orally bioavailable next generation capsid assembly modulator that is in Phase 1b study clinical trial for the treatment of chronic hepatitis B virus (HBV) infection; and ABI-7272, an oral broad-spectrum NNPI for the treatment of transplant-associated herpesviruses. It has an option, license, and collaboration agreement with Gilead Sciences, Inc. for the research and development of virology therapies. The company was formerly known as Ventrus Biosciences, Inc. and changed its name to Assembly Biosciences, Inc. in June 2014. Assembly Biosciences, Inc. was incorporated in 2005 and is headquartered in South San Francisco, California.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Assembly Biosciences (ASMB) Stock Price Today?
The Assembly Biosciences stock price today is 29.800 USD.
What Stock Exchange Does Assembly Biosciences Trade On?
Assembly Biosciences is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Assembly Biosciences?
The stock symbol for Assembly Biosciences is "ASMB."
What Is the Assembly Biosciences Market Cap?
As of today, Assembly Biosciences market cap is 606.750M USD.
What Is Assembly Biosciences's Earnings Per Share (TTM)?
The Assembly Biosciences EPS (TTM) is -0.003.
When Is the Next Assembly Biosciences Earnings Date?
Assembly Biosciences will release its next earnings report on Nov 11, 2026.
From a Technical Analysis Perspective, Is ASMB a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Assembly Biosciences Stock Split?
Assembly Biosciences has split 2 times.
How Many Employees Does Assembly Biosciences Have?
Assembly Biosciences has 73 employees.
What is the current trading status of Assembly Biosciences (ASMB)?
As of Sep 13, 2026, Assembly Biosciences (ASMB) is trading at a price of 29.800 USD, with a previous close of 30.460 USD. The stock has fluctuated within a day range of 29.680 USD to 31.720 USD, while its 52-week range spans from 20.230 USD to 39.705 USD.
What Is Assembly Biosciences (ASMB) Price Target According to Analysts?
The average 12-month price target for Assembly Biosciences is 52.000 USD, with a high estimate of 62 USD and a low estimate of 43 USD. 5 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +74.50% Upside potential.
What Is the ASMB Premarket Price?
ASMB's last pre-market stock price is 30.840 USD. The pre-market share volume is 1,070.000, and the stock has decreased by 0.380, or 1.250%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.